Ollyy / Shutterstock.com
Jazz Pharmaceuticals has sued Watson Laboratories for patent infringement in order to stop the company making a generic version of its flagship product Xyrem (sodium oxybate).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Xyrem, ANDA, Jazz Pharmaceuticals, Watson Laboratories, US District Court for the District of New Jersey, patents
